Anavex’s pipeline has at least 14 indications and one undisclosed indication on its pipeline chart (I noticed cancer is gone from the list, thankfully). This includes AD, PDD, Rett Syndrome, Infantile Spasms, FragileX, Angelman’s Syndrome, Schizophrenia, Frontotemporal Dementia, Depression, Stroke, Neurodegenerative Diseases (undisclosed and no number given), Visceral Pain, and Acute and Neuropathic Pain.
No small biotech company, especially one run by a one-man-band autocratic CEO, could possibly pursue all of these indications. It’s ridiculous.
The guy’s ego is beyond massive. It borders on pathological.